Nucleoside derivative and use thereof

US12398170B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12398170-B2
Application numberUS-202017771089-A
CountryUS
Kind codeB2
Filing dateOct 28, 2020
Priority dateOct 28, 2019
Publication dateAug 26, 2025
Grant dateAug 26, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a nucleoside derivative represented by the following formula (1): or a salt thereof, wherein R 1 represents an alkoxy group, a hydrogen atom or a halogen atom; R 2 and R 4 , which may be the same as or different from each other, each represents a hydrogen atom, a protective group for a hydroxyl group, a phosphate group, a protected phosphate group, or —P(═O) n R 5 R 6 in which n represents 0 or 1, R 5 and R 6 , which may be the same as or different from each other, each represents a hydrogen atom, a hydroxyl group, a protected hydroxyl group, a mercapto group, a protected mercapto group, an alkoxy group, a cyanoalkoxy group, an amino group, or a substituted amino group, provided that when n is 1, both R 5 and R 6 cannot be the hydrogen atom at the same time; R 3 represents —(CH 2 ) m NHR 7 in which m represents an integer of 1 to 6, R 7 represents a hydrogen atom, an alkyl group, an alkenyl group or a protective group for an amino group; and B represents a purin-9-yl group, a 2-oxo-pyrimidin-1-yl group, a substituted purin-9-yl group, or a substituted 2-oxo-pyrimidin-1-yl group.

First claim

Opening claim text (preview).

The invention claimed is: 1. A nucleoside derivative represented by the following formula (1): or a salt thereof, wherein R 1 represents a methoxy group; R 2 and R 4 , which may be the same as or different from each other, each represents a hydrogen atom, a protective group for a hydroxyl group, a phosphate group, a protected phosphate group, or —P (=O) n R 5 R 6 in which n represents 0 or 1, R 5 and R 6 , which may be the same as or different from each other, each represents a hydrogen atom, a hydroxyl group, a protected hydroxyl group, a mercapto group, a protected mercapto group, an alkoxy group, a cyanoalkoxy group, an amino group, or a substituted amino group, provided that when n is 1, both R 5 and R 6 cannot be the hydrogen atom at the same time; R 3 represents —(CH 2 ) m NHR 7 in which m represents 2, R 7 represents a hydrogen atom, an alkyl group, an alkenyl group or a protective group for an amino group; and B represents a purin-9-yl group, a 2-oxo-pyrimidin-1-yl group, a substituted purin-9-yl group, or a substituted 2-oxo-pyrimidin-1-yl group. 2. The nucleoside derivative or the salt thereof according to claim 1 , wherein R 7 represents a hydrogen atom. 3. An oligonucleotide derivative comprising at least one partial structure represented by the following formula (2): or a salt thereof, wherein, R 1 represents a methoxy group; R 3 represents —(CH 2 ) m NHR 7 in which m represents 2, and R 7 represents a hydrogen atom, an alkyl group, an alkenyl group, or a protective group for an amino group; and B represents a purin-9-yl group, a 2-oxo-pyrimidin-1-yl group, a substituted purin-9-yl group, or a substituted 2-oxo-pyrimidin-1-yl group. 4. The oligonucleoside derivative or the salt thereof according to claim 3 , wherein R 7 represents a hydrogen atom. 5. An siRNA comprising the oligonucleotide derivative or the salt thereof according to claim 3 as an active ingredient.

Assignees

Inventors

Classifications

  • interfering nucleic acids [NA] · CPC title

  • Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title

  • with ribosyl as saccharide radical · CPC title

  • Other alkyl chain · CPC title

  • of the sugar · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12398170B2 cover?
Provided is a nucleoside derivative represented by the following formula (1): or a salt thereof, wherein R 1 represents an alkoxy group, a hydrogen atom or a halogen atom; R 2 and R 4 , which may be the same as or different from each other, each represents a hydrogen atom, a protective group for a hydroxyl group, a phosphate group, a protected phosphate group, …
Who is the assignee on this patent?
National Univ Corporation Tokai National Higher Education And Research System, Yamasa Corp
What technology area does this patent fall under?
Primary CPC classification C07H19/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).